Browsing Tag
Aliso Viejo
2 posts
Glaukos (NYSE: GKOS) targets $1bn in sales. Can Epioxa offset iDose risk?
Glaukos shares surged in after-hours trading after the company raised its 2026 revenue forecast and introduced a US$1 billion sales target for 2027. But the ambitious outlook depends on a successful Epioxa rollout and continued demand for iDose TR, whose Medicare coverage remains under review.
Medit expands from intraoral scanners to orthodontic workflows with Progressive Orthodontics deal
Digital dentistry is moving beyond scanners. Medit’s Progressive Orthodontics deal puts education, aligners and workflow control in play.